Effects of Rosemary Essential Oil on Human Cognition
NCT07563114, Not applicable, Active not recruiting, Federal University of Paraíba
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Rosemary Essential Oil on Human Cognition | ClinicalTrials.gov |
| NCT number | NCT07563114 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 63 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Federal University of Paraíba | ClinicalTrials.gov |
| Conditions | Aromatherapy, Cognition | ClinicalTrials.gov |
| Interventions | rosemary1 | ClinicalTrials.gov |
| First posted | 2026-05-01 | ClinicalTrials.gov |
| Last updated | 2026-05-01 | ClinicalTrials.gov |
Registered outcomes 7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | STROOP TEST | Cognitive tests were administered at the following stages: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | Unit of measurement: time (seconds) | ClinicalTrials.gov |
| Primary | Subteste Digits of the Test WAIS-III - (Wechsler Adult Scale) | Cognitive tests were administered at the following stages: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1a. Maximum raw score: 30 1b. Minimum raw score: 2 | ClinicalTrials.gov |
| Primary | Subtest Number and Letter Sequence of the WAIS-III Test - (Wechsler Adult Scale) | Cognitive test were administered at the following times: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1.0 Measurement Units: raw score 1a. Maximum raw score: 21 1b. Minimum raw score: 0 | ClinicalTrials.gov |
| Primary | Tower of London | Cognitive test were administered at the following times: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1.0 Measurement Units: raw score 1a. Maximum raw score: 46 1b. Minimum raw score: 0 | ClinicalTrials.gov |
| Primary | Token Test | Cognitive test were administered at the following times: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1.0 Measurement Units: raw score 1a. Maximum raw score: 36 1b. Minimum raw score: 0 | ClinicalTrials.gov |
| Primary | Corsi Blocks | Cognitive test were administered at the following times: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1.0 Measurement Units: raw score 1a. Maximum raw score: 30 1b. Minimum raw score: 0 | ClinicalTrials.gov |
| Primary | Hopkins Verbal Learning | Cognitive test were administered at the following times: "Before the intervention (baseline), immediately after the intervention, and 1 week after the intervention." | 1.0 Measurement Units: raw score 1a. Maximum raw score: 0 1b. Minimum raw score: 36 | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Corsi Block-Tapping Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Token Commands Task | Primary outcome | ConductCognition |
| Tower Planning | Primary outcome | ConductCognition |
| Verbal Learning | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)